Tags: Drug.
Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors that is currently under clinical development by Recombio an international public-private consortium with the participation of the Center of Molecular Immunology at Havana Cuba (CIM) and researchers from Buenos Aires University and National University of Quilmes in Argentina.